1-201900318-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012134.3(LMOD1):c.695C>T(p.Thr232Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000488 in 1,597,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012134.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMOD1 | NM_012134.3 | c.695C>T | p.Thr232Ile | missense_variant | 2/3 | ENST00000367288.5 | NP_036266.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMOD1 | ENST00000367288.5 | c.695C>T | p.Thr232Ile | missense_variant | 2/3 | 1 | NM_012134.3 | ENSP00000356257 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000397 AC: 6AN: 151308Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000322 AC: 7AN: 217092Hom.: 0 AF XY: 0.0000342 AC XY: 4AN XY: 116846
GnomAD4 exome AF: 0.0000498 AC: 72AN: 1445988Hom.: 0 Cov.: 35 AF XY: 0.0000460 AC XY: 33AN XY: 717798
GnomAD4 genome AF: 0.0000397 AC: 6AN: 151308Hom.: 0 Cov.: 31 AF XY: 0.0000406 AC XY: 3AN XY: 73802
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2021 | The c.695C>T (p.T232I) alteration is located in exon 2 (coding exon 2) of the LMOD1 gene. This alteration results from a C to T substitution at nucleotide position 695, causing the threonine (T) at amino acid position 232 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at